ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
37.26
+0.02 (0.05%)
Apr 30, 2026, 11:28 AM CST
ChengDu ShengNuo Biotec Market Cap
ChengDu ShengNuo Biotec has a market cap or net worth of 5.86 billion as of April 29, 2026. Its market cap has increased by 75.66% in one year.
Market Cap
5.86B
Enterprise Value
6.14B
Revenue
801.40M
Ranking
n/a
PE Ratio
33.24
Stock Price
37.26
Market Cap Chart
Since June 3, 2021, ChengDu ShengNuo Biotec's market cap has increased from 5.24B to 5.86B, an increase of 11.84%. That is a compound annual growth rate of 2.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 5.86B | -1.46% |
| Dec 31, 2025 | 5.95B | 106.10% |
| Dec 31, 2024 | 2.89B | -8.63% |
| Dec 29, 2023 | 3.16B | 77.68% |
| Dec 30, 2022 | 1.78B | -39.31% |
| Dec 31, 2021 | 2.93B | -44.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Luoxin Pharmaceuticals Group Stock | 5.86B |
| Chongqing Pharscin Pharmaceutical | 5.82B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 5.70B |
| Jinghua Pharmaceutical Group | 6.06B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 6.09B |
| HPGC Renmintongtai Pharmaceutical | 5.61B |
| Jiangsu Jibeier Pharmaceutical | 5.58B |
| ChengDa Pharmaceuticals | 6.25B |